SIEGALL CLAY B (President and CEO) purchased 28.9% of their position (150K shares) of IMMUNOME INC. on the open market
Open‑market purchase worth $1.16M — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/3/2025ACC: 0001415889-25-002824
DirectorOfficer· President and CEO
Since Oct 2023
+150K
Net shares
Net buyer
$1.16M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
150K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+150K
Price / share
$7.75
Trade value
$1.16M
% of position
28.9%
1/31/2025
519.64K→669.64K
Total
Net shares
+150K
Net value
$1.16M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/31/2025 | P · Purchase | +150K | $7.75 | $1.16M | 28.9% | 519.64K | 669.64K |
| Total | +150K | $1.16M | ||||||
Derivative Transactions0
No derivative transactions reported